
Get exclusive money-saving offers and guides
Straight to your inbox
Updated
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Palla Pharma Limited is a farm products business based in Australia. Palla Pharma shares (PAL) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Palla Pharma has a trailing 12-month revenue of around $39.7 million..
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
52-week range | $0.45 - $1.08 |
---|---|
50-day moving average | $0.7611 |
200-day moving average | $0.7892 |
Target price | N/A |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.087 |
Standard brokerage - Australian shares
Competitive broker fees on Australian and international shares
Important: Share trading carries risk of capital loss.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of A$0.665 on 2021-01-22
1 week (2021-01-16) | N/A |
---|---|
1 month (2020-12-24) | -11.33% |
3 months (2020-10-23) | -7.64% |
6 months (2020-07-24) | -32.14% |
1 year (2020-01-24) | -34.16% |
---|---|
2 years (2019-01-24) | -43.64% |
3 years (2018-01-25) | -71.94% |
5 years (2016-01-25) | -81.48% |
Valuing Palla Pharma stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Palla Pharma 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Palla Pharma 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $49,582.
The EBITDA is a measure of a Palla Pharma 's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $39.7 million |
---|---|
Gross profit TTM | $17.3 million |
Return on assets TTM | -6.82% |
Return on equity TTM | -23.42% |
Profit margin | -31.7% |
Book value | 0.49 |
Market capitalisation | $83.8 million |
TTM: trailing 12 months
We're not expecting Palla Pharma to pay a dividend over the next 12 months.
Over the last 12 months, Palla Pharma 's shares have ranged in value from as little as $0.45 up to $1.08. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Palla Pharma 's is 1.2503. This would suggest that Palla Pharma 's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Palla Pharma Limited, a vertically integrated pharmaceutical company, produces and distributes narcotic raw materials, active pharmaceutical ingredients, and finished dosage formulations for pharmaceutical markets in Australia and Norway. It also produces and distributes poppy seeds to culinary markets. The company was formerly known as TPI Enterprises Limited and changed its name to Palla Pharma Limited in June 2019. The company was founded in 2004 and is based in Docklands, Australia.
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
Steps to owning and managing ETFS FANG+ ETF units.
Steps to owning and managing ETFS S&P Biotech ETF units.
Steps to owning and managing ETFS Reliance India Nifty 50 ETF units.
Steps to owning and managing BetaShares India Quality ETF units.